<SEC-DOCUMENT>0001493152-25-028988.txt : 20251223
<SEC-HEADER>0001493152-25-028988.hdr.sgml : 20251223
<ACCEPTANCE-DATETIME>20251223153645
ACCESSION NUMBER:		0001493152-25-028988
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20251223
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251223
DATE AS OF CHANGE:		20251223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CEMTREX INC
		CENTRAL INDEX KEY:			0001435064
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRONIC COMPONENTS & ACCESSORIES [3670]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37464
		FILM NUMBER:		251600160

	BUSINESS ADDRESS:	
		STREET 1:		276 GREENPOINT AVE. BLD 8 SUITE 208
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11222
		BUSINESS PHONE:		631 756 9116

	MAIL ADDRESS:	
		STREET 1:		276 GREENPOINT AVE. BLD 8 SUITE 208
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11222
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:CETX="http://cemtrex.com/20251223">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03C_CETX_cemtrex.com_20251223 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20251223_20251223 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0001435064 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-12-23" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-12-23" id="Fact000004" name="dei:EntityCentralIndexKey">0001435064</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="cetx-20251223.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-12-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001435064</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-12-23</xbrli:startDate>
        <xbrli:endDate>2025-12-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt; background-color: white"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90F_edei--DocumentType_c20251223__20251223_zmqPWQv3DMP"><ix:nonNumeric contextRef="AsOf2025-12-23" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PURSUANT
TO SECTION 13 OR 15(d) OF</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SECURITIES EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
of Report (Date of earliest event reported): <span id="xdx_900_edei--DocumentPeriodEndDate_c20251223__20251223_zPSnbG3GD6tg"><ix:nonNumeric contextRef="AsOf2025-12-23" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">December 23, 2025</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="form8-k_001.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span style="text-decoration: underline"><span id="xdx_900_edei--EntityRegistrantName_c20251223__20251223_zM7lGKO8yVr7"><ix:nonNumeric contextRef="AsOf2025-12-23" id="Fact000011" name="dei:EntityRegistrantName">Cemtrex
Inc.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--EntityIncorporationStateCountryCode_c20251223__20251223_zkhOo46KpVoj"><ix:nonNumeric contextRef="AsOf2025-12-23" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--EntityFileNumber_c20251223__20251223_zEhqhpBE7Xn8"><ix:nonNumeric contextRef="AsOf2025-12-23" id="Fact000013" name="dei:EntityFileNumber">001-37464</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20251223__20251223_zA7BYyU7sZki"><ix:nonNumeric contextRef="AsOf2025-12-23" id="Fact000014" name="dei:EntityTaxIdentificationNumber">30-0399914</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
                                            Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--EntityAddressAddressLine1_c20251223__20251223_zib5uZcDuQ1a"><ix:nonNumeric contextRef="AsOf2025-12-23" id="Fact000015" name="dei:EntityAddressAddressLine1">135
                                            Fell Court</ix:nonNumeric></span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--EntityAddressCityOrTown_c20251223__20251223_zfdM9cRxMKHa"><ix:nonNumeric contextRef="AsOf2025-12-23" id="Fact000016" name="dei:EntityAddressCityOrTown">Hauppauge</ix:nonNumeric></span>,
    <span id="xdx_908_edei--EntityAddressStateOrProvince_c20251223__20251223_zQSIEmQNEu09"><ix:nonNumeric contextRef="AsOf2025-12-23" id="Fact000017" name="dei:EntityAddressStateOrProvince">NY</ix:nonNumeric></span></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--EntityAddressPostalZipCode_c20251223__20251223_zJNQc4lJnT3h"><ix:nonNumeric contextRef="AsOf2025-12-23" id="Fact000018" name="dei:EntityAddressPostalZipCode">11788</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <span style="text-decoration: underline"><span id="xdx_90B_edei--CityAreaCode_c20251223__20251223_zQqQBXcRIw3l"><ix:nonNumeric contextRef="AsOf2025-12-23" id="Fact000019" name="dei:CityAreaCode">(631)</ix:nonNumeric></span> <span id="xdx_904_edei--LocalPhoneNumber_c20251223__20251223_z0n1LrezrLU5"><ix:nonNumeric contextRef="AsOf2025-12-23" id="Fact000020" name="dei:LocalPhoneNumber">756-9116</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--WrittenCommunications_c20251223__20251223_z041qnNaqlah"><ix:nonNumeric contextRef="AsOf2025-12-23" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--SolicitingMaterial_c20251223__20251223_zGSuy6vSGrx"><ix:nonNumeric contextRef="AsOf2025-12-23" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--PreCommencementTenderOffer_c20251223__20251223_zqYzBn9Oyuge"><ix:nonNumeric contextRef="AsOf2025-12-23" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--PreCommencementIssuerTenderOffer_c20251223__20251223_zckvaDWISu8l"><ix:nonNumeric contextRef="AsOf2025-12-23" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4I under the Exchange Act (17 CFR 240.13I(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_902_edei--EntityEmergingGrowthCompany_c20251223__20251223_zakNwgKEHqa5"><ix:nonNumeric contextRef="AsOf2025-12-23" format="ixt:booleanfalse" id="Fact000025" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    symbol</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--Security12bTitle_c20251223__20251223_zyVJJmTHaBei"><ix:nonNumeric contextRef="AsOf2025-12-23" id="Fact000026" name="dei:Security12bTitle">Common
    Stock</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--TradingSymbol_c20251223__20251223_zOb0jpIIzmMj"><ix:nonNumeric contextRef="AsOf2025-12-23" id="Fact000027" name="dei:TradingSymbol">CETX</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_90C_edei--SecurityExchangeName_c20251223__20251223_z9ZpxQlCS0R7"><ix:nonNumeric contextRef="AsOf2025-12-23" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span>
    Capital Market</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: center; text-indent: -1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: center; text-indent: -1in"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: center; text-indent: -1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: center; text-indent: -1in"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: center; text-indent: -1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT ON FORM 8-K</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cemtrex,
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01. Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 23, 2025, Cemtrex, Inc. (the &#8220;Company&#8221;) entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;)
with a single accredited institutional investor (the &#8220;Purchaser&#8221;), pursuant to which the Company agreed to issue and sell
to the Purchaser, in a registered direct offering (the &#8220;Offering&#8221;), securities consisting of shares of the Company&#8217;s
common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), and/or pre-funded warrants to purchase shares of Common Stock
(the &#8220;Pre-Funded Warrants&#8221;), for aggregate gross proceeds of $2,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.4in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Offering closed on December 23, 2025. The Company issued 330,000 shares of common stock and prefunded warrants to purchase 470,000 shares
of common stock. The Purchase Agreement contains customary representations, warranties, and covenants by the Company and the Purchaser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.4in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the
full text of the Purchase Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein
by reference. The Doney Law Firm, counsel to the Company, delivered an opinion as to the legality of the issuance and sale of the securities,
a copy of which is attached hereto as Exhibit 5.1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.4in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01 Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued a press release announcing the Offering on December 23, 2025. A copy of the press release is attached hereto as Exhibit
99.1, and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    Title</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-1.htm">Form of Pre-Funded Common Stock Purchase Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex5-1.htm">Opinion of The Doney Law Firm</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Securities Purchase Agreement, dated December 23, 2025</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex5-1.htm">Consent of The Doney Law Firm (contained in Exhibit 5.1)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release dated December 23, 2025</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEMTREX,
    INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    December 23, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Saagar Govil</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Saagar
    Govil</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman,
    President, and Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6LDoriu5Nh4o4RcYQX4uLUtyakdY5P8m/tNsQQyAk954bIQZiSxtdIMNllSaQYVkVyiGkeENGc0XviHf7CPxM8a6tY2Vct/7AmDyDnpkNJ8rfO2etLeYRjOVITkZyCuE8mi5geRBBq8dkbjpH47QqQJkcTkwVa3SK331CphoyVL67T2dkq8n4uGHYyx+Q4VjCkWr1In5YSJJYBIOuArFlelbetW4cmpaEdYGlf2d7+t/BF8lISlg= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ex4-1.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRE-FUNDED
COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CEMTREX
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: 470,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Initial
    Exercise Date: December 23, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Avondale Capital, LLC,
a Utah limited liability company, or its assigns (the &ldquo;<U>Holder</U>&rdquo;), is entitled, upon the terms and subject to the limitations
on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;)
until this Warrant is exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase
from Cemtrex Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to 470,000 shares (as subject to adjustment hereunder,
the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be
equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated December 23, 2025, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. The Company shall have no obligation to inquire with respect to or otherwise confirm the authenticity of the signature(s)
contained on any Notice of Exercise nor the authority of the person so executing such Notice of Exercise. Notwithstanding anything herein
to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased
all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this
Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered
to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available
hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the
applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares
purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise on the Trading Day of receipt
of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions
of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase
hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.001 per Warrant Share,
was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the
nominal exercise price of $0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of
this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price
under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination
Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.001, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo;
in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by
(A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
    = </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined
    in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the highest Bid Price of
    the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) withing two (2) hours
    of the time of the Holder&rsquo;s delivery of the Notice of Exercise pursuant to Section 2(a) hereof if such Notice of Exercise is
    delivered during &ldquo;regular trading hours,&rdquo; or within two (2) hours after the close of &ldquo;regular trading hours&rdquo;
    on a Trading Day or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading
    Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after two (2) hours following the
    close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    = </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
    = </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX Best
Market (&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or
the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB
or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;) operated by
the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and
reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a
certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares
to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date
that is the earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading
Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant
Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have
become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of
delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period
following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery
Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m.
(New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase Agreement,
the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise
Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including reasonable and customary brokerage commissions, if any) for the shares of Common Stock
so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver
to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation
was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares
for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of
shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.
For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted
exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A)
of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written
notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount
of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in
equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure
to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith and the calculations
required under this Section 2(e). To the extent that the limitation contained in this Section 2(e) applies, the determination of whether
this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties)
and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of
Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities
owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each
case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such
determination and shall have no liability for exercises of this Warrant that are in noncompliance with the Beneficial Ownership Limitation.
In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the
Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding
shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s
most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company
or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.
Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the
number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined
after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates
or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall be 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to
the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or
decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no
event exceeds 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares
of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any
increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to
the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to
such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time while the Warrant is
outstanding, the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other
property pro rata to the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder
will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could
have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation); provided, that such Purchase Right shall terminate on, and shall not be held in abeyance for any
period subsequent to the Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised
at the time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the
Holder has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, after giving effect to such
transaction, the stockholders of the Company immediately prior to such transaction own less than 50% of the aggregate voting power of
the Company or the successor entity of such transaction, (ii) the Company (all of its Subsidiaries, taken as a whole), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in
one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the
Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares
for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding Common Stock or greater
than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, after giving effect to such transaction,
the stockholders of the Company immediately prior to such transaction own less than 50% of the aggregate voting power of the Company
or the successor entity of such transaction, or (v) the Company, directly or indirectly, in one or more related transactions consummates
a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires greater
than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power of the common equity of the Company (each
a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right
to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number
of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional
consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of
the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without
regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price
among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other
Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably
satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at
the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written
instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise
of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an
exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value
of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of
shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior
to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon
the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this
Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant
and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and the Successor
Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the
Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume
all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if
the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the avoidance
of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of (i) whether the Company has
sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs
prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Cemtrex Inc.
    </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Saagar Govil</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Cemtrex Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: _____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _______________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: _____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
______________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: ___________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: ____________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ex5-1.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 48%; vertical-align: middle; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 16pt; font-variant: small-caps"><B>The
                                            Doney Law Firm</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">Securities
    &amp; Corporate Law</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott
                                            P. Doney, Esq.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3651
    Lindell Rd Ste D121</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Las
    Vegas, NV 89103</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">702.982.5686</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">scott@doneylawfirm.com</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
23, 2025</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cemtrex,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">135
Fell Court</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hauppauge,
NY 11788</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Re:
Registered Direct Offering of Common Stock and Pre-Funded Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have acted as counsel to Cemtrex, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), in connection with the issuance and sale
by the Company pursuant to the Securities Purchase Agreement, dated December 23, 2025 (the &ldquo;Purchase Agreement&rdquo;), between
the Company and Avondale Capital, LLC (the &ldquo;Purchaser&rdquo;), of (i) shares of the Company&rsquo;s common stock, par value $0.001
per share (the &ldquo;Common Stock&rdquo;), and/or (ii) pre-funded warrants to purchase shares of Common Stock (the &ldquo;Pre-Funded
Warrants&rdquo; and, together with the Common Stock, the &ldquo;Securities&rdquo;), in an aggregate amount of up to $2,000,000 (the &ldquo;Offering&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Offering is being made pursuant to the Company&rsquo;s effective shelf registration statement on Form S-3 (Registration No. 333-283995)
(the &ldquo;Registration Statement&rdquo;), including the base prospectus dated February 3, 2025, as supplemented by the prospectus supplement
dated December 23, 2025 (the &ldquo;Prospectus Supplement&rdquo; and, together with the base prospectus, the &ldquo;Prospectus&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this opinion, we have examined and relied upon the Registration Statement, the Prospectus, the Purchase Agreement, the
form of Pre-Funded Warrant, the Company&rsquo;s Certificate of Incorporation and Bylaws (each as amended to date), resolutions of the
Company&rsquo;s Board of Directors, and such other documents and instruments as we have deemed necessary for the purposes of this opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
rendering the opinions set forth below, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the
authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as
certified or photostatic copies, and the authenticity of the originals of such copies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon the foregoing, and subject to the qualifications, assumptions, and limitations stated herein, we are of the opinion that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company is a corporation duly organized, validly existing, and in good standing under the
                                            laws of the State of Delaware.</FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Securities have been duly authorized by the Company and, when issued and delivered against
                                            payment therefor in accordance with the Purchase Agreement, will be validly issued, fully
                                            paid, and non-assessable.</FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            shares of Common Stock issuable upon exercise of the Pre-Funded Warrants (the &ldquo;Warrant
                                            Shares&rdquo;), when issued and delivered upon exercise of the Pre-Funded Warrants in accordance
                                            with the terms thereof, will be validly issued, fully paid, and non-assessable.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
opinion is limited to the General Corporation Law of the State of Delaware and applicable federal securities laws of the United States.
We express no opinion as to the laws of any other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
opinion is rendered solely for your benefit in connection with the Offering and may not be relied upon by any other person or for any
other purpose without our prior written consent. We assume no obligation to update or supplement this opinion to reflect any facts or
circumstances that may hereafter come to our attention or any changes in law that may hereafter occur.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the filing of this opinion as Exhibit 5.1 to the Current Report on Form 8-K to be filed by the Company on December
23, 2025, and to the reference to our firm under the caption &ldquo;Legal Matters&rdquo; in the Prospectus Supplement. In giving this
consent, we do not admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act of
1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Doney Law Firm</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="ex5-1_001.jpg" ALT="" STYLE="height: 85px; width: 100px"></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott
Doney, Esq.</FONT></P>

</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5pt"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of December 23, 2025, between Cemtrex Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors
and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities
Act (as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires
to purchase from the Company, securities of the Company as more fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I.</B><BR>
DEFINITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the third (3rd) Trading
Day following the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Time</U>&rdquo; means 9:30 AM New York City time on December 23, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers, directors or consultants of the
Company pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of
Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to
the Company, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder, and/or other securities
exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided
that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease
the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations)
or to extend the term of such securities, and (c) securities issued pursuant to acquisitions or strategic transactions approved by a
majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo;
(as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection
therewith during the prohibition period in Section 4.11(a) herein, and provided that any such issuance shall only be to a Person (or
to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business
synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds,
but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an
entity whose primary business is investing in securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(aa).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Per
Share Purchase Price</U>&rdquo; equals $2.50, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement, provided that the purchase price per
Pre-Funded Warrant shall be the Per Share Purchase Price minus $0.001.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrant</U>&rdquo; means, collectively, the Pre-Funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, which Pre-Funded Warrants shall be exercisable immediately and shall expire when exercised in full, in the
form of <U>Exhibit A</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the base prospectus included in the Registration Statement at the time the Registration Statement first became effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the final supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with
the Commission and delivered by the Company to each Purchaser at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement with Commission file No. 333-283995 which registers the sale of the Shares,
the Pre-Funded Warrants and the Pre-Funded Warrant Shares to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Pre-Funded Warrants and the Pre-Funded Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares and/or Pre-Funded Warrants purchased hereunder
as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo;
in United States dollars and in immediately available funds (minus, if applicable, a Purchaser&rsquo;s aggregate exercise price of the
Pre-Funded Warrants, which amounts shall be paid as and when such Pre-Funded Warrants are exercised).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U>, and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Pre-Funded Warrants, all exhibits and schedules thereto and hereto and any other documents
or agreements executed in connection with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means ClearTrust, LLC, the current transfer agent of the Company, with an email address of inbox@cleartrusttransfer.com,
and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section 4.11(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II.</B><BR>
PURCHASE AND SALE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Closing</U>. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the
Purchasers, severally and not jointly, agree to purchase, up to an aggregate of $2,000,000.00 of Shares; <U>provided</U>, <U>howeve</U>r,
that, to the extent that a Purchaser determines, in its sole discretion, that such Purchaser (together with such Purchaser&rsquo;s Affiliates,
and any Person acting as a group together with such Purchaser or any of such Purchaser&rsquo;s Affiliates) would beneficially own in
excess of the Beneficial Ownership Limitation, or as such Purchaser may otherwise choose, in lieu of purchasing Shares such Purchaser
may elect to purchase Pre-Funded Warrants in lieu of Shares in such manner to result in the same aggregate purchase price being paid
by such Purchaser to the Company, less $0.001 per Pre-Funded Warrant purchased. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Securities
on the Closing Date. The Company shall deliver to each Purchaser its respective Shares and a Pre-Funded Warrant, if applicable, as determined
pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at
the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices
of Hansen Black Anderson Ashcraft PLLC in Lehi, Utah or such other location as the parties shall mutually agree take place remotely by
electronic transfer of the Closing documentation. Notwithstanding anything to the contrary herein and a Purchaser&rsquo;s Subscription
Amount set forth on the signature pages attached hereto, the number of Shares purchased by a Purchaser (and its Affiliates) hereunder
shall not, when aggregated with all other shares of Common Stock owned by such Purchaser (and its Affiliates) at such time, result in
such Purchaser beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act) in excess of 4.99% of the then
issued and outstanding Common Stock outstanding at the Closing (the &ldquo;<U>Beneficial Ownership Maximum</U>&rdquo;), and such Purchaser&rsquo;s
Subscription Amount, to the extent it would otherwise exceed the Beneficial Ownership Maximum immediately prior to the Closing, shall
be conditioned upon the issuance of Shares at the Closing to the other Purchasers signatory hereto. To the extent that a Purchaser&rsquo;s
beneficial ownership of the Shares would otherwise be deemed to exceed the Beneficial Ownership Maximum, such Purchaser&rsquo;s Subscription
Amount shall automatically be reduced as necessary in order to comply with this paragraph. Notwithstanding the foregoing, with respect
to any Notice(s) of Exercise (as defined in the Pre-Funded Warrants) delivered on or prior to 12:00 p.m. (New York City time) on the
Closing Date, which may be delivered at any time after the time of execution of this Agreement, the Company agrees to deliver the Pre-Funded
Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Closing Date and the Closing Date shall be the Warrant
Share Delivery Date (as defined in the Pre-Funded Warrants) for purposes hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to the Closing Date (except as indicated below), the Company shall deliver or cause to be delivered to each Purchaser (or
such other party as applicable) the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a legal opinion provided by the Company&rsquo;s counsel, directed to the Purchasers, in a form reasonably acceptable to the Purchasers;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
subject to Section 2.1, the Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on Company letterhead
and executed by the Chief Executive Officer or Chief Financial Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
each Purchaser&rsquo;s respective Shares registered in the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
for each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser to purchase
up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Pre-Funded
Warrant divided by the Per Share Purchase Price minus $0.001, with an exercise price equal to $0.001, subject to adjustment therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
filed the press release described in Section 4.4 below prior to the Disclosure Time; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
the Prospectus and Prospectus Supplement, which shall have been filed with the Commission (which may be delivered in accordance with
Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by such Purchaser; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
such Purchaser&rsquo;s Subscription Amount, which shall be paid via wire transfer of immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects)
on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in
which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality,
in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been
performed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless
as of a specific date therein in which case they shall be accurate in all material respects or, to the extent representations or warranties
are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
there shall have been no Material Adverse Effect with respect to the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III.</B><BR>
REPRESENTATIONS AND WARRANTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall
be deemed a part hereof and shall qualify any representation made herein to the extent of the disclosure contained in the corresponding
section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. All of the direct and indirect subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. The Company
owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and
all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and
free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references
to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the results of operations, assets, business or condition (financial or otherwise) of the
Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material
respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;)
and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail
such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no
further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith
other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been
(or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will
constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as
limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings
required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) application(s)
to each applicable Trading Market for the listing of the Shares and Pre-Funded Warrant Shares for trading thereon in the time and manner
required thereby, and (iv) such filings as are required to be made under applicable state securities laws (collectively, the &ldquo;<U>Required
Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Issuance of the Securities; Registration</U>. The Securities are duly authorized and, when issued and paid for in accordance with
the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed
by the Company. The Pre-Funded Warrant Shares, when issued in accordance with the terms of the Pre-Funded Warrants, will be validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized capital
stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Pre-Funded Warrants. The Company has prepared
and filed the Registration Statement in conformity with the requirements of the Securities Act, which became effective on February 3,
2025 (the &ldquo;<U>Effective Date</U>&rdquo;), including the Prospectus, and such amendments and supplements thereto as may have been
required to the date of this Agreement. The Registration Statement is effective under the Securities Act and no stop order preventing
or suspending the effectiveness of the Registration Statement or suspending or preventing the use of the Prospectus has been issued by
the Commission and no proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission.
The Company, if required by the rules and regulations of the Commission, shall file the Prospectus Supplement with the Commission pursuant
to Rule 424(b). At the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement and
at the Closing Date, the Registration Statement and any amendments thereto conformed and will conform in all material respects to the
requirements of the Securities Act and did not and will not contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus, the Prospectus Supplement
and any amendments or supplements thereto, at the time the Prospectus, the Prospectus Supplement or any amendment or supplement thereto
was issued and at the Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and
did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading. The Company was at the time of the filing of the
Registration Statement eligible to use Form S-3. The Company is eligible to use Form S-3 under the Securities Act and it meets the transaction
requirements as set forth in General Instruction I.B.6 of Form S-3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Capitalization</U>. The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule
3.1(g)</U> shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as
of the date hereof. The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act,
other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans, the issuance of shares of
Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise
of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has
any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated
by the Transaction Documents. Except as a result of the purchase and sale of the Securities and set forth on <U>Schedule 3.1(g)</U>,
there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to,
or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe
for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements
by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents
or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue
shares of Common Stock or other securities to any Person (other than the Purchasers). There are no outstanding securities or instruments
of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such security or
instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding securities or instruments of the
Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings
or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary.
The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement.
All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have
been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of
any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder,
the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting
agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge
of the Company, between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and
the Prospectus Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received
a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their
respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act,
as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements
of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and
regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in
accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and
its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included
within the SEC Reports, except as set forth on <U>Schedule 3.1(i)</U>, (i) there has been no event, occurrence or development that has
had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent
or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings
made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment
of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth on <U>Schedule 3.1(i)</U>, no
event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with
respect to the Company or its Subsidiaries or their respective businesses, properties, operations, assets or financial condition that
would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made
that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Litigation</U>. Except as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding
or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their
respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state,
county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on <U>Schedule 3.1(j)</U>, (i)
adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii)
could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company
nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or
liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of
the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former
director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration
statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local
and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that
has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor
has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational
health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be
expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Environmental Laws</U>.&#9;The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws
relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface
or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants,
or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise
relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials,
as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters,
orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;);
(ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective
businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i),
(ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or
modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of
which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which
the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None
of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights
has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date
of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included
within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe
upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge
of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any
of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy,
confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company
nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase
in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Transactions With Affiliates and Employees</U>. None of the officers or directors of the Company or any Subsidiary and, to the knowledge
of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any
Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing
for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of
money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge
of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director,
trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for
services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock
option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements
of the Sarbanes-Oxley Act of 2002, as amended that are effective as of the date hereof, and any and all applicable rules and regulations
promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries
maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with
management&rsquo;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets
at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and
designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it
files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s
rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of
the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act
(such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange
Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations
as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as
such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely
to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Certain Fees</U>. No brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company or any Subsidiary to any
broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions
contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims
made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions
contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Registration Rights</U>. No Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities
Act of any securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. Except as set forth in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received
notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance
with the listing or maintenance requirements of such Trading Market. Except as set forth in the SEC Reports, the Company is, and has
no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements.
The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation
and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in
connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company
fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of
the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or
counsel with any information that it believes constitutes or might constitute material, non-public information which is not otherwise
disclosed in the Prospectus Supplement. The Company understands and confirms that the Purchasers will rely on the foregoing representation
in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers
regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure
Schedules to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.
The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not
contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances under which they were made and when made, not misleading. The Company
acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated
hereby other than those specifically set forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market
on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its
business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)
the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Closing Date. <U>Schedule 3.1(aa)</U> sets forth as of the date hereof all outstanding
secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For
the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess
of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other
contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s
consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection
or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due
under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to
any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Tax Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income
and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)
has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material
taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material
amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no
basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any
agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>Accountants</U>. The Company&rsquo;s accounting firm is set forth on <U>Schedule 3.1(dd)</U> of the Disclosure Schedules. To the knowledge
and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall
express its opinion with respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year
ending December 31, 2024.&#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Acknowledgment Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(f) and 4.14 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been
asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the
Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified
term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales
or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage
in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the
periods that the value of the Pre-Funded Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging
activities (if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the time that the
hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach
of any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>Regulation M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>Cybersecurity</U>. (i)(x) There has been no security breach or other compromise of or relating to any of the Company&rsquo;s or any
Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data (including the data of its respective
customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively,
&ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of
any event or condition that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and
Data; (ii) the Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders,
rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations
relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use,
access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii)
the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards to maintain and protect its material
confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and Data; and (iv) the Company
and the Subsidiaries have implemented backup and disaster recovery technology consistent with industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Compliance with Data Privacy Laws</U>. (i) The Company and the Subsidiaries are, and at all times during the last three (3) years
were, in compliance with all applicable state, federal and foreign data privacy and security laws and regulations, including, without
limitation, the European Union General Data Protection Regulation (&ldquo;<U>GDPR</U>&rdquo;) (EU 2016/679) (collectively, &ldquo;<U>Privacy
Laws</U>&rdquo;); (ii) the Company and the Subsidiaries have in place, comply with, and take appropriate steps reasonably designed to
ensure compliance with their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure,
handling and analysis of Personal Data (as defined below) (the &ldquo;<U>Policies</U>&rdquo;); (iii) the Company provides accurate notice
of its applicable Policies to its customers, employees, third party vendors and representatives as required by the Privacy Laws; and
(iv) applicable Policies provide accurate and sufficient notice of the Company&rsquo;s then-current privacy practices relating to its
subject matter, and do not contain any material omissions of the Company&rsquo;s then-current privacy practices, as required by Privacy
Laws. &ldquo;<U>Personal Data</U>&rdquo; means (i) a natural person&rsquo;s name, street address, telephone number, email address, photograph,
social security number, bank information, or customer or account number; (ii) any information which would qualify as &ldquo;personally
identifying information&rdquo; under the Federal Trade Commission Act, as amended; (iii) &ldquo;personal data&rdquo; as defined by GDPR;
and (iv) any other piece of information that allows the identification of such natural person, or his or her family, or permits the collection
or analysis of any identifiable data related to an identified person&rsquo;s health or sexual orientation. (i) None of such disclosures
made or contained in any of the Policies have been inaccurate, misleading, or deceptive in violation of any Privacy Laws and (ii) the
execution, delivery and performance of the Transaction Documents will not result in a breach of any Privacy Laws or Policies. Neither
the Company nor the Subsidiaries (i) to the knowledge of the Company, has received written notice of any actual or potential liability
of the Company or the Subsidiaries under, or actual or potential violation by the Company or the Subsidiaries of, any of the Privacy
Laws; (ii) is currently conducting or paying for, in whole or in part, any investigation, remediation or other corrective action pursuant
to any regulatory request or demand pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement by or with any
court or arbitrator or governmental or regulatory authority that imposed any obligation or liability under any Privacy Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance
with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the
Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity
of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and
warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case
they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and
in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to
which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof,
will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except:
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Understandings or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct
or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this
representation and warranty not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or
otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the
ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each
date on which it exercises any Pre-Funded Warrants, it will be an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2),
(a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the
Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition,
results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the
opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that
is necessary to make an informed investment decision with respect to the investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has
not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser
first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material
terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV.</B><BR>
OTHER AGREEMENTS OF THE PARTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Pre-Funded Warrant Shares</U>. If all or any portion of a Pre-Funded Warrant is exercised at a time when there is an effective registration
statement to cover the issuance or resale of the Pre-Funded Warrant Shares or if the Pre-Funded Warrant is exercised via cashless exercise,
the Pre-Funded Warrant Shares issued pursuant to any such exercise shall be issued free of all legends. If at any time following the
date hereof the Registration Statement (or any subsequent registration statement registering the sale or resale of the Pre-Funded Warrant
Shares) is not effective or is not otherwise available for the sale or resale of the Pre-Funded Warrant Shares, the Company shall immediately
notify the holders of the Pre-Funded Warrants in writing that such registration statement is not then effective and thereafter shall
promptly notify such holders when the registration statement is effective again and available for the sale or resale of the Pre-Funded
Warrant Shares (it being understood and agreed that the foregoing shall not limit the ability of the Company to issue, or any Purchaser
to sell, any of the Pre-Funded Warrant Shares in compliance with applicable federal and state securities laws). The Company shall use
commercially reasonable efforts to keep a registration statement (including the Registration Statement) registering the issuance or resale
of the Pre-Funded Warrant Shares effective during the term of the Pre-Funded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Furnishing of Information</U>. Until the time that no Purchaser owns Securities, the Company shall use commercially reasonable efforts
to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed
by the Company after the date hereof pursuant to the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the
rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction
unless shareholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Securities Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material
terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company
represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers
by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, in connection
with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the
Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral,
between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees, Affiliates or agents,
on the one hand, and any of the Purchasers or any of their Affiliates on the other hand, shall terminate and be of no further force or
effect. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions
in securities of the Company. The Company and each Purchaser shall consult with each other in issuing any other press releases with respect
to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor otherwise make
any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser, or without the
prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably be withheld or
delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with
prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name
of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market,
without the prior written consent of such Purchaser, except (a) as required by federal securities law in connection with the filing of
final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations,
in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b) and reasonably
cooperate with such Purchaser regarding such disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person,
that any Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill
(including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by
the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Non-Public Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such
information and agreed in writing with the Company to keep such information confidential. The Company understands and confirms that each
Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company,
any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public
information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall
not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees,
Affiliates or agents, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, employees, Affiliates
or agents, not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable
law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information
regarding the Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice with the
Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the
foregoing covenant in effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Use of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder for general corporate purposes
including but not limited to working capital or for future acquisitions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Indemnification of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser
and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;Purchaser Party&rdquo;) harmless from any and all
losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements,
court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result
of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement
or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their
respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the
transactions contemplated by the Transaction Documents, unless such action is solely based upon a breach or claimed breach of such Purchaser
Party&rsquo;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser
Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct
by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct. If any action
shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party
shall promptly notify the Company in writing, and, the Company shall have the right to assume the defense thereof with counsel of its
own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any
such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser
Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company
has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable
opinion of counsel a material conflict on any material issue between the position of the Company and the position of such Purchaser Party,
in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company
will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company&rsquo;s
prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss,
claim, damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants
or agreements made by a Purchaser Party in this Agreement or the other Transaction Documents. The indemnification required by this Section
4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are
received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any
Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep
available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company
to issue Shares pursuant to this Agreement and Pre-Funded Warrant Shares pursuant to any exercise of the Pre-Funded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Listing of Common Stock</U>. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation
of the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply
to list or quote all of the Shares and Pre-Funded Warrant Shares on such Trading Market and promptly secure the listing of all of the
Shares and Pre-Funded Warrant Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock
traded on any other Trading Market, it will then include in such application all of the Shares and Pre-Funded Warrant Shares, and will
take such other action as is necessary to cause all of the Shares and Pre-Funded Warrant Shares to be listed or quoted on such other
Trading Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading
of its Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s reporting, filing and other obligations
under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer
through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of
fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
<U>Subsequent Equity Sales</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Subject to the provisions of Section 4.11(c), from the date hereof until 60 days after the Closing Date, neither the Company nor any
Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock
or Common Stock Equivalents or (ii) file any registration statement or amendment or supplement thereto, other than (a) the Prospectus
Supplement, or (b) filing a registration statement on Form S-8 in connection with any employee benefit plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Subject to the provisions of Section 4.11(c), from the date hereof until the 90-day anniversary of the Closing Date, the Company shall
be prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common
Stock or Common Stock Equivalents (or a combination of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate
Transaction</U>&rdquo; means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible
into, exchangeable or exercisable for, or include the right to receive additional shares of Common Stock either (A) at a conversion price,
exercise price or exchange rate or other price that is based upon and/or varies with the trading prices of or quotations for the shares
of Common Stock at any time after the initial issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange
price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence
of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or
(ii) enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit or an &ldquo;at-the-market
offering&rdquo;, whereby the Company may issue securities at a future determined price regardless of whether shares pursuant to such
agreement have actually been issued and regardless of whether such agreement is subsequently canceled; <U>provided</U>, <U>however</U>,
that, after 60 days after the Closing Date, the entry into and/or issuance of shares of Common Stock in an &ldquo;at the market&rdquo;
offering will not be considered a Variable Rate Transaction. Any Purchaser shall be entitled to obtain injunctive relief against the
Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding the foregoing, Section 4.11(a) and Section 4.11(b) shall not apply in respect of an Exempt Issuance, except that no Variable
Rate Transaction shall be an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
<U>Equal Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid
to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat
the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the
purchase, disposition or voting of Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13
<U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that
neither it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including
Short Sales of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at
such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as
described in Section 4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described
in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included
in the Disclosure Schedules (other than as disclosed to its legal and other representatives). Notwithstanding the foregoing and notwithstanding
anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation,
warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the
transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section
4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance
with applicable securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced
pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty
not to trade in the securities of the Company to the Company, any of its Subsidiaries, or any of their respective officers, directors,
employees, Affiliates, after the issuance of the initial press release as described in Section 4.4. Notwithstanding the foregoing, in
the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such
Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect to the portion of
assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14
<U>Capital Changes</U>. Until the one year anniversary of the Closing Date, the Company shall not undertake a reverse or forward stock
split or reclassification of the Common Stock without the prior written consent of the Purchasers holding a majority in interest of the
Shares and Pre-Funded Warrants other than a reverse stock split that is required, in the good faith determination of the Board of Directors,
to maintain the listing of the Common Stock on the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15
<U>Exercise Procedures</U>. The form of Notice of Exercise included in the Pre-Funded Warrants set forth the totality of the procedures
required of the Purchasers in order to exercise the Pre-Funded Warrants. No additional legal opinion, other information or instructions
shall be required of the Purchasers to exercise their Pre-Funded Warrants. Without limiting the preceding sentences, no ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise form be required in order to exercise the Pre-Funded Warrants. The Company shall honor exercises of the Pre-Funded Warrants
and shall deliver Pre-Funded Warrant Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V.</B><BR>
MISCELLANEOUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without
any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the
Closing has not been consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>,
that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including,
without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice
delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus
Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior
agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such
documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is
delivered via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New
York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later
than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if
sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required
to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares and Pre-Funded
Warrants based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case
of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification
or waiver disproportionately and adversely impacts a Purchaser (or multiple Purchasers), the consent of such disproportionately impacted
Purchaser (or at least 50.1% in interest of such multiple Purchasers) shall also be required. No waiver of any default with respect to
any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any
subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party
to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately,
materially and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the
other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with
this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>No Third-Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise
set forth in Section 4.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of Utah, without regard to the principles
of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of
the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective
affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and
federal courts sitting in the Salt Lake City, Utah. Each party hereby irrevocably submits to the exclusive jurisdiction of the state
and federal courts sitting in the Salt Lake City, Utah for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents),
and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the
jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party
hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing
a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect
for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.
If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the
obligations of the Company under Section 4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing
party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and prosecution
of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission
of an exercise of a Pre-Funded Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any
such rescinded exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for
such shares and the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Pre-Funded
Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction
Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that
a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16
<U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by
or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17
<U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document
are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other
Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as
a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way
acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of
this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
of the Transaction Documents. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the
convenience of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood
and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser,
solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18
<U>Liquidated Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19
<U>Saturdays, Sundays, Holidays, etc.</U>&#9;If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20
<U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21
<B><U>WAIVER OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CEMTREX INC.</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Address for Notice:</U></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"></TD>
  <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Saagar Govil</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">E-Mail:</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">With a copy to (which shall not constitute notice):</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE FOR PURCHASER FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[PURCHASER
SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">CETX</FONT> SECURITIES PURCHASE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Purchaser: Avondale Capital, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Purchaser</I>: _________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: John Fife</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: President</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
Address of Authorized Signatory: jfife@chicagoventure.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Notice to Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">297
Auto Mall Drive #4</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">St.
George, Utah 84770</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
Amount: $2,000,000.00</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares:
330,000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Funded Warrant
  Shares: 470,000 </FONT></TD>
  <TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial Ownership
  Blocker &#9746; 4.99% or &#9744; 9.99%</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN
Number: 33-2898944</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;
<FONT STYLE="font-size: 10pt">Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations
of the above-signed to purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and
the obligations of the Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall
be disregarded, (ii) the Closing shall occur on the first (1st) Trading Day following the date of this Agreement and (iii) any condition
to Closing contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company
or the above-signed of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition
and shall instead be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument,
certificate or the like or purchase price (as applicable) to such other party on the Closing Date.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGES CONTINUE]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 32; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%; text-align: left">December 23, 2025</TD><TD STYLE="text-align: right; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT=""></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cemtrex,
Inc. Announces $2 Million Registered Direct Offering</B></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hauppauge,
NY, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Cemtrex, Inc. (NASDAQ: CETX,</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CETXP)
(the &ldquo;Company&rdquo;), an advanced security technology and industrial services company, today announced that it has entered into
a definitive agreement for the purchase of approximately 800,000 shares and / or pre funded warrants with a single institutional investor,
at a purchase price of $2.50 per share, with gross proceeds to the Company expected to be $2 million to the Company.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction is expected to close on or about Dec 23, 2025, subject to the satisfaction of customary closing conditions. The Company expects
to use the net proceeds from the offering, for general corporate purposes, including working capital and potential acquisitions.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offering is being made pursuant to an effective shelf registration statement on Form S-3 (No. 333-283995) previously filed with the U.S.
Securities and Exchange Commission (SEC) and declared effective by the SEC on February 3, 2025. A final prospectus supplement and accompanying
prospectus describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC&rsquo;s website
located at www.sec.gov.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interested
parties should read in their entirety the prospectus supplement and the accompanying prospectus and the other documents that the Company
has filed with the SEC that are incorporated by reference in such prospectus supplement and the accompanying prospectus, which provide
more information about the Company and such offering.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities
in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="text-indent: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">About
Cemtrex, Inc.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cemtrex,
Inc. (Nasdaq: CETX) is a diversified technology company operating in the Security and Industrial sectors. Its Security segment, led by
Vicon Industries, provides advanced video management software, high-performance security cameras, and integrated surveillance solutions
for enterprise, government, and critical infrastructure. The Industrial segment, through Advanced Industrial Services (AIS), delivers
expert rigging, millwrighting, process piping, and equipment installation services to manufacturers nationwide. With a focus on innovation,
execution, and strategic growth, Cemtrex is committed to enhancing safety, efficiency, and value for its customers and shareholders.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information visit www.cemtrex.com.</FONT></P>

<P STYLE="text-indent: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-Looking
Statements</FONT></P>




<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing material may contain &ldquo;forward-looking statements&rdquo; within the meaning of Section 27A of the Securities Act of 1933
and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not
relate solely to historical or current facts, including without limitation statements regarding the Company&rsquo;s product development
and business prospects, and can be identified by the use of words such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo;
&ldquo;project,&rdquo; &ldquo;estimate,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;plan,&rdquo; &ldquo;believe,&rdquo; &ldquo;potential,&rdquo;
&ldquo;should,&rdquo; &ldquo;continue&rdquo; or the negative versions of those words or other comparable words. Forward-looking statements
are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to
the Company and its current plans or expectations and are subject to a number of risks and uncertainties that could significantly affect
current plans. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual
results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although the Company believes
that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, performance,
or achievements. Except as required by applicable law, including the security laws of the United States, the Company does not intend
to update any of the forward-looking statements to conform these statements to actual results.</FONT></P>

<P STYLE="text-indent: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor
Relations</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">investors@cemtrex.com</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor
Relations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">investors@cemtrex.com</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT=""></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source:
Cemtrex Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>form8-k_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form8-k_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  @ *L# 2(  A$! Q$!_\0
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M-&+8^LM1\0:9I5S:VMU=QI<W4HAAASEW8]..N/>O'/V@3C5-"_ZXR_S6N*\
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84#&!<1I:/M#C@D<=#C/XTZEG[RZC/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !M ( # 2(  A$! Q$!_\0
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4% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  6 '@# 2(  A$! Q$!_\0
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M-C9R))K=S$!(9+2VN[F>5D=564L$;\JOV4O^"TW['&C_ /!0+1O@#\3O@/\
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MJ7Q ^/7[47_!1GQE^U7\.O'W[+VJ0>#/AYKVN?$_4;CP5XOUU/#_ (QTGQ=
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MHE[8:KX5NM+O[#4-"M[TW!O[6RND_$W]C']L+]J?_@E=_P %;OB'_P $\/\
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MB<M2$57A96Y^;F2;L[-=.:WW']CW_!?/_@F3^U5^VK^U-^RA\:OV;?B!\%O
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>2JI5%3C"#DU%&CC&,8<JLFF[=+N4GIVU;?S]$O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>cetx-20251223.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaOA6bP9z5Z8aekhvWBxbYl6HyUmcmlG7CAi0qCm4fIL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:CETX="http://cemtrex.com/20251223" elementFormDefault="qualified" targetNamespace="http://cemtrex.com/20251223">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://cemtrex.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="cetx-20251223_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cetx-20251223_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>cetx-20251223_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>cetx-20251223_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="cetx-20251223.xsd#Cover" roleURI="http://cemtrex.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://cemtrex.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 23, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 23,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cemtrex
Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001435064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">30-0399914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">135
                                            Fell Court<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Hauppauge<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(631)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">756-9116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CETX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cemtrex.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cetx-20251223.xsd</File>
    <File>cetx-20251223_lab.xml</File>
    <File>cetx-20251223_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>form8-k_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "CETX",
   "nsuri": "http://cemtrex.com/20251223",
   "dts": {
    "schema": {
     "local": [
      "cetx-20251223.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cetx-20251223_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cetx-20251223_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://cemtrex.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-23",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-23",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cemtrex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001493152-25-028988-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-25-028988-xbrl.zip
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M!VWQ3*D7(F9B9.(XG=.8['XA>[!=ALXM$X#--A2:*" J[,X +"HQ*M1(R+V
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M3'UT-B2DIZ/[H&P3]="\LNTGK@]#3F;E.(\D0)X=#*"E;K"(OJ<Z5FSAN%2
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MNUT\D)D]'M<#F02'](J"T'"@Y)LOL(X2E*LDL;CTYL\M$[03"D6I'/R,""\
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MQE 2IHOVB:];N\&]G;;XQOUR;V"U6_X'4$L#!!0    ( )5\EUM!0LXHO9,
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MO]MNP"AVGS-0<O.FZ7K]PBG[I<SQC'S <'1CU1G<GB>?87N7I[0]I9G]DM^
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M7P /DOM'>0.2 =: 1P\?XJ9Z'[34#_]\:PK"1 PZDSBC? H*>:C%H/GE7*4
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M9UQ]VQ5O6J_';#HY5*#+S#B%8EDUJ 7.."&"3=P5K$<USV="9V%NQI//PL*
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M0*4DWU,8H_(52="].^_>Z/>1V?XJ#&T^.=;^DA<^JN%3'^$M6D0R]:I:]%Z
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M]!\Q9A\+=@EOA[@#9^-Q0(PKI=)!ZG+0AO[@<$VTGN;(<11@Y^M]R=BK=>&
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MIN@X7:/JZ$0-8-$C?3&(M;<NV=]T#O$-\.TBA\_Q@I!8*DR#*QO5P;V:;U(
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MGQ@%=Z_7:]]V%+!;42B8%J;-]KH#_)I N8JN1UH:J*!JG BAKT9JV!!(0@:
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M#0*1]^JUIT]Q*M:V(U\#Z=CO]@[;/1TI]L+!.B2Z U'I4J0:?W?7\;D=Y[&
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M4<+8L(RWBGH/IF62T-7P;EOS"??B(2^*FY(92!;H?DISD@NKF9^Z,B4P1^3
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MU#PK(OPZ6Z(M$$0QQQW@<?Q="I==G.QB @C_[O>N/_=AT_[ *<(_YV#YL9=
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M-OD[6_6R;6 /' 6C$EM-4D-;U0$'OX&FOH*ZU?4<9JP?I*O&]B]+]6TQ[.X
MPP&&VH T+0:(0",>L*97D6-*3C2*6$LM#D4 @*3P*J"K"&-QS2P1AM5<-18U
M3(TPASTOT7G,45:,QYAJH)PSILHDQKZ]'5DM(0%Q.KE-X@-0-B6]0B6:XGFA
M<'DC@<3H"E)=A.%.J7AFY^((FPR.V+%<E%:NA9T@C]J2AY5A53N7ZM^EE*X.
MCJ59-WG^HTP[TE9DN32[ #=;;J-#JAWTH[F!G!3DY"26*I-#IW\YB0Z% T1O
MY^91&EE$V>W+D*L%N1K6:O2V<>9<N#YE2>6)M.4IN;E)JK1L=2X2.A!.VDC7
M):?+(EODM4#8I;GY)UP6V$=)S\]2.!^SI5>IX.ERJ@L=^V02I8T3]BNF3+%4
M6QA/%<@H'$,MD[SX$G>2!'JH^?= (G%<HJ>&JB-,+!@L E,CKR3-NV2*(('-
MW =LG9S@1Q_NHUT"-Q=>CQ&3R'&M6%7V4OZ#,4>522:%0NRV$@G)+96IB[L6
MKACOP-[UG_B(5E24,ZZW4U=N.>$=')#087$AYB$HCA.V, ,B$K09K.$H &J&
M=$K.W=JG58R'DD+IDTBNGC=NQ92K,%@]Y?9"*J3U9=M&JGHN-^V0TU4TDU#)
M7J%DU9KK7?J7E )S<P9XIEEXX"KHEL>>8L8-W=BZM+:_0JE>]89[V>K;;$U*
M;?T05;^U\ P?]4(NH)<[U5:Q^5F;^+0%:59ZA!.UZ.;@%KRI<$_&^V0'=YH'
MIN)+]_"KN<K0JBN+)NH=#$P!=S?!75-R*JY4JV\"4:V^N:;U)<VGM4(*)RC3
MU0M4$)Z*]Q"\:EHO:H&V$K#/"J,+0,T@/:C%RCU![DX)355R:-@AK:)M3OJS
M%:YVDLL;?+9*$;,JRI-B48&<0H1Q9Y];P,9=PP-T$PI!(1LED')X@)I@_OG>
M_]A(QCKT0^A*+KV*6N=L3,PUV<3<N"8?$Q23?$R=_'+K:JLZ.Q<DV8,ODNV0
M3J+ 1J:)L1'DS41W.D&'D-OH^!,V^, =,DU0)!!QY]3OSW"A/]C?^="_V(?^
M8'_G1-\Z)_HWAU3]64.JGEM&B'#1':3JEO@\!5)5':'TA5%]%KUX/<E15H1-
M7M(F2!XE&3J2D<E?&++^K,<%38UJQ;G=/>M3:/&&2O&3]MB-;![1V\ PRK%(
M'\W=B499=+03--40&GV:<U.9*5>GN9V"3!Z=*6%KC.G:V*+Y3:[;@5NF1/,@
M[0D$4YDGG)8P62"TK8GGD\.2.F)[W;0M1%AM8,XX#<PIGIFH/"-)TM(;&J'I
MDTZTRJE*X+G+=XON1EELN"":J%*2P: $JE,[!,OYH REED[NO+<)J]/R]XJ[
MCFN;-E0=4EBM%H10L?OM?V/>0T,]MK(@T3=BE2,:4"8&%U/&-#U2^ N1+$NM
M$G8TA0)-#F91J,7$RNQJX(=JYS<UG ,QFV4(]?FZJ)'^3* N7V(/F:GJ!6 2
MU. PRV5+HHD@5ZA39'JY6%:H8*#ZJ,_;;?'D=/8(%KD4<5G8+95>E)=&EP.1
M8O*KSF!N!Z"Q>MNO'%NZYM07)=#%X-'0[IVCS4C7J+:&$C)$O[UUVGPI>2#C
MS.3?^QUHU(+8>-!50>G$M%#0&^'F.JL&=J'J!F% '2@U%^E)*D,TSJI5=.I'
M'A07O8BHXL6E1PZH[H)O6[(L@35];4ZP:A&NJHE(RK8ZHY>,R*'$M>LDH#1#
M)3XOC1^9(XJO02$/HQ)>16EL9*&3,-<I]+1/D-CI4K<PBV82$'/8KKGX%H':
M?C&F59 G?&E&2Z>THTO\[:'O0/70&W=TJOQY$ U#JWV<EHA.5Q;R(E]:4D$!
M!U/!J56SV>:AN+:0\[+YD];GQ&/()VU-H[V7G>/IP2P5,QXG5J# EZ57=J5P
M95QTL4+F@@$X%4\G_(F'PNML:4,V!RC]R$A5'AGK0>.W6!=,U557QH7#"M*.
MD6W)L@3-T ]=='5D+U5HPRVQ)<[%/F1U%= M)VV&O!8#?(VB6@<9!B3%3054
MVV1,"7"+VBG>:Z7:,-.D]';",D$JAC_=]2 KP=0J5NBPKIF5";7"1'^O89FP
M(A6-*'J5, *8'K490'$JT^0QY6[V , ,&PTY39X*<S#61UQ=Y9*%.#BE0HSK
M!46&;4^E4B9_D#NXQI/X8.=)_')/XH.=)W'G2;RN)_&Q]B2^2BLTB#DJM/,A
M;@FWC522J()C!\%W9G)M@O<$?*B2J(!K8&N&NN;6A2BFCZ+JHL4JBHN$LP D
M:&>;^Z+V"YZ(9/[T>[%N"J4A6DH]I\C. .HH6%+!5%<*P\LF_.8 )\3#00JZ
MAM&$=<"NWVM]Y=%>\,'VDHJS1R<8F,["=H\53YW&TDM5Z(:Q<W+:J$FKDC>E
M:I,GR,QX/)1VDNK;%'P7;U][ PU9)C?:<GYV.10'5<@M6"7.*5CHUO:.2&/2
M,6TPHVH>N")*0*]-9UO:.W=A[B@?$%_'RZ*"AT"%GH#"?YR@&W:LW+:O0(/-
M=-J<'2QR=.YQ 63$YC+J_\IJ2-*YWS8</Z,*X5>B A@XUHSF5_/\8G=^,V=^
MCC8OFCAG((Y1WZ+\$U5;;0I0W;LJ^CEF$XJWSQI?FK6J&824J@?',\NE>%&#
M '15%_/*5+\WKU>2-9M0)5_;3=_8H5W5$BN@>UKDL92N>G$7_)$XK-U"7VN#
M&IM#[E/95.Z>8+EAJ:&,(-:O<+$T=QPW,?V(!<WDK\]C\7%P<I-@H9N9TKYD
M:;+PITSNE\;G=_QF2Y8E+HFSJ%Z4F!P)3V)A*O[E5\H&P[\E]=CI"DFYFD@U
M\SD6 2<QM;%6UGBM V<4)]!\@96">5IJTM<RVXJX$/!91!^5L(T3FHF"0P47
M=QRI%G]<*\ #B=>2,RP+R3OC01J!!8GTY;####C#J-IJA'X/AMA1\I8L2X!W
M#TS)-@N/79W5]=/7-EO4@YM=TKDMUUSM)6S)*+35A$:+EYH%(X9W2E#/R3U)
M@1)#'22><PD!N( X#@9 HX23^\&COM1:_=]47TQ.@:V>D\&D IABN30Q'O;Z
M/5NIFRQ*,L@\Y2Z58$9;FQ.5DZ]S52E JW:B%O6GDC!7B1"7!<6?8&;E5*)G
MTM=RP=FV.)2.:R6(#($E!ILLVHG:=B_:463I)&M2<3@03NG+&FY*P>A4BK^;
M&0F EX*4=#0MF:4*<DF);662?47ZJ$#R95IDMN "E=14#F31%:/=3A=*7;)*
M:EBVS6P$.166?Q65'Q-1SIUZ%D.-,L,,'>5QAXHO>>>1"6[I.+@3RN-5;GPR
M92(!4A57L*&M4DQ;:$.(NMYW"&Z%#6?3T,6/?'5D"F!@#G.#S*T..2L<C1<5
M.$5JAYN&D5P<*P>RJ2HD$ 5X-<%<"<;G(4+[A$P*5-V<P[5\#:I@3'"LC0"+
M"X&HF$&B4M>QDTE]H5!<.=7(?<6)O#(F$&-TPG;-,*%=I7>;8":-,+RUY.5O
MPOT_)]SP<!=N^/)PP\-=N&';P@T;WM ;5SI/R$,KF&).R0P(SJN(L$D%RHR9
M/4:G[73-MA01,NR6EJUH]13KR(8%8<$%BZBW>$X->-?%1*XORF(QO1!1[&*&
M.Z6?4MK940?E%% Z'549O=GI/&R*E$T%IH8R1,@K]DLE'TE%H1_@QA0C5%=5
M:P?0<ZE>R(*Q$PG#_8$]/2_L]Q"]D+0ET05J.E\0-],"%.9)1'E*506:A/%R
ME26E*.$>2_TKI[MR"V*3/&I9]>H9!?W>HGJ1'6_!$HO27*O:+>.I5U6@7G3
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M!"K=VP6TK%Q)67(EZ7";*L,&YHSUS>-$XP9A:* $R[]N#P::Y%I=^D_52YL
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MR;(RR8W'Q!DTA[OA<V9%S!A@*#9F3&]*43/D*26=DO*C#7*%@".1QI:+86N
M.^K9DF7-A'U3DS_;<OF =(#.YSDH%RG!S9$>T>FFM2!Q5&S0 A:2]MR10C4Q
M*,#(JRC.V.^QPN3F7K-/-9VL]A&;P>&1BW24BGK'2/GX]:#]XPSEIS]KF&::
MFRFZ^7#*&Z]&DEPT&8>BI2JS37X66?W($<XEMGSZMF HK6<H!ZY;:NPNV)8L
M*^<+]FM"10&6!7,A/\'\J2;\."H%2@N@GA)YJIP%U*25_Y&K'ITJVS+4-H%
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MEUM_5?G_]@H  &Y,   )    97@U+3$N:'1M[5QK<]JZ%OW.#/]!ESG-M#-
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MQB-$&9#SHB%>7HK?,TSMC+B%U [5P'K(F0LHY2F&QQ1YR:@U1N10Z Q;!3Y
M9  (88<2;H05DOVS6)COYE10:>-3XT0(J<K&GHB@5:&!80LKPH$H_8#[,!7)
MM4HGT,;!V@2FFBF%H(;Q&O!&(+9*=O!L[I]QL]VXD:A-,F'P>-& @%F(2PM
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MD^OO+'Z0"T7"?@OVF0Z=QLZ>#<[>C4ZC4(>B<[.:' &=ZC@*>DH,?1X,RUG
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M&(_7_2MPG*KD2Y)NT&HYA-DU4," ?6!K#,A<JG@F[X2%P%-S,7R+4HVHA5D
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MQ\9H]3%;?YX[<BYW7#'"9WA^L8%X"XW[R:S9ZRU;;=W?_CK5"LV)W2>K()'
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M7JVWU?Z)TR*)KJY,^,^!-5)+_P]02P,$%     @ E7R76YPM:02A"@  *PL
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M>"TR,#(U,3(R,RYX<V102P$"% ,4    " "5?)=;F&0V[OT*  !_A@  %0
M            @ %6 P  8V5T>"TR,#(U,3(R,U]L86(N>&UL4$L! A0#%
M  @ E7R76R-;W"58!P  TE<  !4              ( !A@X  &-E='@M,C R
M-3$R,C-?<')E+GAM;%!+ 0(4 Q0    ( )5\EUM!0LXHO9,  'MY P *
M          "  1$6  !E>#$P+3$N:'1M4$L! A0#%     @ E7R76YT%MMN]
M00   ;$!  D              ( !]JD  &5X-"TQ+FAT;5!+ 0(4 Q0    (
M )5\EUM_5?G_]@H  &Y,   )              "  =KK  !E>#4M,2YH=&U0
M2P$"% ,4    " "5?)=;0']+K;$*  #T+@  "@              @ 'W]@
M97@Y.2TQ+FAT;5!+ 0(4 Q0    ( )5\EUN&/"['BQ0  #>H   +
M      "  = ! 0!F;W)M."UK+FAT;5!+ 0(4 Q0    ( )5\EUN<+6D$H0H
M "L+   /              "  806 0!F;W)M."UK7S P,2YJ<&=02P4&
/  D "0 9 @  4B$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cetx-20251223.xsd" xlink:type="simple"/>
    <context id="AsOf2025-12-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001435064</identifier>
        </entity>
        <period>
            <startDate>2025-12-23</startDate>
            <endDate>2025-12-23</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="AsOf2025-12-23" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-12-23" id="Fact000004">0001435064</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-12-23" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-12-23" id="Fact000010">2025-12-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-12-23" id="Fact000011">Cemtrex Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-12-23" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-12-23" id="Fact000013">001-37464</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-12-23" id="Fact000014">30-0399914</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-12-23" id="Fact000015">135                                             Fell Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-12-23" id="Fact000016">Hauppauge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-12-23" id="Fact000017">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-12-23" id="Fact000018">11788</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-12-23" id="Fact000019">(631)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-12-23" id="Fact000020">756-9116</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-12-23" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-12-23" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-12-23" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-12-23" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-12-23" id="Fact000025">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="AsOf2025-12-23" id="Fact000026">Common     Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-12-23" id="Fact000027">CETX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-12-23" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
